Telix Pharma Upsizes Convertible Bond Deal to $600 Million
Telix Pharmaceuticals Ltd. raised $600 million from a convertible bond deal that fetched more than expected, in a sign of strong demand for Australia’s largest such offering this year. The company’s shares fell.
Original Source
Read the full article at Bloomberg →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.